RankingsPricing
  1. JP-listed companies
  2. SanBio Company Limited
  3. Financials
  4. EBITDA

SanBio Company Limited【JP:4592】

Market cap
¥122.2B
P/E ratio
-30.2x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEBITDA (Million JPY)YoY (%)
Jan 31, 2025-3,507-22.50%
Jan 31, 2024-4,524-42.54%
Jan 31, 2023-7,874+21.38%
Jan 31, 2022-6,488+13.29%
Jan 31, 2021-5,727+5.14%
Jan 31, 2020-5,446+47.32%
Jan 31, 2019-3,697-14.51%
Jan 31, 2018-4,325+126.96%
Jan 31, 2017-1,905+71.49%
Jan 31, 2016-1,111-149.29%
Jan 31, 20152,254

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)